Rating History for Eleven Biotherapeutics (EBIO) by Laidlaw

More Stocks Rated by Laidlaw | Latest Ratings for EBIO
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/10/2018 N/A New Coverage Buy
(N/A)		 8.00
(N/A)		 2.83
(3.29)		 16.25% Details